A shadow market for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.
Experimental Treatment Gaining Popularity Online
The experimental drug, which is still in clinical trials, is being advertised by online personalities for its supposed fat-burning properties. Followers are urged to contact these accounts directly for supplier links, while also obtaining discount codes.
Active Trade on Social Networks
Additionally, a robust market exists on Telegram, where communities with numerous of members share “before and after” images, injection guides and assertions of rapid UK delivery. Sellers market the drug there before directing buyers to WhatsApp for purchases.
Understanding The Experimental Drug
This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Medical Experts Voice Concerns
However, doctors and chemists have cautions that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could lead to individuals administering products of uncertain source.
Some professionals said the demand for retatrutide could be linked to the rising cost of approved slimming products such as Mounjaro.
Regulatory Position and Implementation
Marketing the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unlicensed drug that must not be promoted or supplied for personal consumption under the British medical regulations.
Several content creators attempt to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still breach medicines, marketing, and customer laws, potentially leading to penalties, prosecution or prison.
Platform Response and Material Removal
According to TikTok, the platform has taken down problematic content and banned related keywords and search suggestions. The company stated it was committed to maintaining the platform safe and allocating resources in enhancing compliance measures.
Digital Marketplace Operations
Research also discovered communities with up to 9,000 members marketing retatrutide using Telegram's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately displays channels with thousands of members, filled with photos of weight loss, glowing testimonials and step-by-step guides for mixing or administering at residence.
After moments of joining one group, a seller shared WhatsApp details, where most transactions occur. The vendor provided an instruction manual and guaranteed shipping within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one asked about body mass, medical conditions or past usage.
Item Information and Costs
Inside these groups, posts display black plastic parcels with Royal Mail stickers, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at residence with purified liquid, or pre-filled pens typically priced at £160 for 20 milligrams. When asked how much time a injector should be used, sellers give contradictory responses varying between a several days to “depends on your body”.
Platform Oversight and Safety Actions
A spokesperson for the messaging service stated it regularly monitored dangerous material on its service including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are injecting substances they can’t verify. Even if the research behind retatrutide is valid, these digital versions may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the surge in interest to current cost increases for authorized weight-loss drugs such as Mounjaro. “With prices rising, individuals are turning to social media. But fake treatments are highly dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she explained.
Her staff has previously seen individuals injured by self-injection from unverified sources. “We understand the frustration, but purchasing from Telegram or communication platforms is taking chances with your well-being,” said the doctor. “These substances could be contaminated or improperly measured.”
Producer Statement
A representative from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this time no one can market [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a Lilly investigational product not yet approved … may subject patients to potentially serious medical dangers”.
